{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:34Z","timestamp":1760853874925,"version":"3.41.0"},"reference-count":131,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128040133"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.irn.2016.02.009","type":"book-chapter","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T15:02:18Z","timestamp":1457362938000},"page":"263-291","source":"Crossref","is-referenced-by-count":30,"title":["Animal Models and the Development of Vaccines to Treat Substance Use Disorders"],"prefix":"10.1016","author":[{"given":"O.","family":"Ohia-Nwoko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.N.","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/bs.irn.2016.02.009_bb0005","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.vaccine.2014.07.085","article-title":"Adjuvants for vaccines to drugs of abuse and addiction","volume":"32","author":"Alving","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/bs.irn.2016.02.009_bb0010","first-page":"25","article-title":"How the research-based industry approaches vaccine development and establishes priorities","volume":"110","author":"Andre","year":"2002","journal-title":"Developmental Biology (Basel)"},{"issue":"16","key":"10.1016\/bs.irn.2016.02.009_bb0015","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0162-3109(92)90023-6","article-title":"A potential vaccine for cocaine abuse prophylaxis","volume":"23","author":"Bagasra","year":"1992","journal-title":"Immunopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2016.02.009_bb0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuropharm.2004.07.007","article-title":"Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats","volume":"47","author":"Barrett","year":"2004","journal-title":"Neuropharmacology"},{"issue":"Suppl. 3","key":"10.1016\/bs.irn.2016.02.009_bb0030","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines\u2014US perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2016.02.009_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"4067","key":"10.1016\/bs.irn.2016.02.009_bb0040","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1126\/science.178.4067.1290","article-title":"Evidence for active immunity to morphine in mice","volume":"178","author":"Berkowitz","year":"1972","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.irn.2016.02.009_bb0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/14712598.8.4.379","article-title":"Vaccines to combat smoking","volume":"8","author":"Bevins","year":"2008","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"5485","key":"10.1016\/bs.irn.2016.02.009_bb0050","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cbi.2012.08.015","article-title":"Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice","volume":"203","author":"Brimijoin","year":"2013","journal-title":"Chemico-Biological Interactions"},{"issue":"6","key":"10.1016\/bs.irn.2016.02.009_bb0060","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1471-4159.1993.tb03518.x","article-title":"Effects of chronic morphine treatment on beta-endorphin-related peptides in the caudal medulla and spinal cord","volume":"60","author":"Bronstein","year":"1993","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1567-5769(00)00019-9","article-title":"Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats","volume":"1","author":"Byrnes-Blake","year":"2001","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.irn.2016.02.009_bb0070","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: An overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1016\/bs.irn.2016.02.009_bb0075","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/mp400214w","article-title":"Probing the effects of hapten stability on cocaine vaccine immunogenicity","volume":"10","author":"Cai","year":"2013","journal-title":"Molecular Pharmaceutics"},{"issue":"6558","key":"10.1016\/bs.irn.2016.02.009_bb0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.irn.2016.02.009_bb0085","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.98.4.1988","article-title":"A second-generation vaccine protects against the psychoactive effects of cocaine","volume":"98","author":"Carrera","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/bs.irn.2016.02.009_bb0090","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1073\/pnas.97.11.6202","article-title":"Cocaine vaccines: Antibody protection against relapse in a rat model","volume":"97","author":"Carrera","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"year":"2015","series-title":"Behavioral health trends in the United States: Results from the 2014 National Survey on Drug use and Health","author":"Center for Behavioral Health Statistics and Quality","key":"10.1016\/bs.irn.2016.02.009_bb9010"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000067433","article-title":"Preclinical development of a vaccine \u2018against smoking\u2019","volume":"25","author":"Cerny","year":"2002","journal-title":"Onkologie"},{"issue":"9","key":"10.1016\/bs.irn.2016.02.009_bb0100","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Therapy"},{"issue":"12","key":"10.1016\/bs.irn.2016.02.009_bb0105","doi-asserted-by":"crossref","first-page":"e82557","DOI":"10.1371\/journal.pone.0082557","article-title":"Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions","volume":"8","author":"Cornish","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/bs.irn.2016.02.009_bb0110","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: A randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/bs.irn.2016.02.009_bb0115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.142.9.1081","article-title":"Naltrexone-induced dysphoria in former opioid addicts","volume":"142","author":"Crowley","year":"1985","journal-title":"The American Journal of Psychiatry"},{"issue":"52","key":"10.1016\/bs.irn.2016.02.009_bb0120","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1016\/j.vaccine.2013.10.051","article-title":"Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum","volume":"31","author":"de Villiers","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/bs.irn.2016.02.009_bb0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00210-004-0960-3","article-title":"Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat","volume":"370","author":"de Villiers","year":"2004","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000063628","article-title":"Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell","volume":"69","author":"de Villiers","year":"2002","journal-title":"Respiration"},{"issue":"22","key":"10.1016\/bs.irn.2016.02.009_bb0135","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","article-title":"Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines","volume":"27","author":"Duryee","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/bs.irn.2016.02.009_bb0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.ajp.2012.12060793","article-title":"Effect of a nicotine vaccine on nicotine binding to beta2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers","volume":"170","author":"Esterlis","year":"2013","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-3057(97)00005-1","article-title":"Active immunization with cocaine-protein conjugate attenuates cocaine effects","volume":"58","author":"Ettinger","year":"1997","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/erv.13.13","article-title":"Therapeutic vaccines against tobacco addiction","volume":"12","author":"Fahim","year":"2013","journal-title":"Expert Review of Vaccines"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10550887.2010.531672","article-title":"Effect of methadone maintenance treatment on heroin craving, a literature review","volume":"30","author":"Fareed","year":"2011","journal-title":"Journal of Addictive Diseases"},{"issue":"5\u20136","key":"10.1016\/bs.irn.2016.02.009_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/FBP.0b013e32830c360e","article-title":"Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: Evidence from genetically modified mice","volume":"19","author":"Fowler","year":"2008","journal-title":"Behavioural Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0162-3109(94)90009-4","article-title":"A potential vaccine for cocaine abuse prophylaxis?","volume":"27","author":"Gallacher","year":"1994","journal-title":"Immunopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jps.2600720314","article-title":"Prediction of stability in pharmaceutical preparations XX: Stability evaluation and bioanalysis of cocaine and benzoylecgonine by high-performance liquid chromatography","volume":"72","author":"Garrett","year":"1983","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0175","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/JVI.79.5.3117-3126.2005","article-title":"Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue","volume":"79","author":"Gillgrass","year":"2005","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/bs.irn.2016.02.009_bb0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1037\/0893-164X.14.4.390","article-title":"Cocaine and methamphetamine: Differential addiction rates","volume":"14","author":"Gonzalez Castro","year":"2000","journal-title":"Psychology of Addictive Behaviors"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"Gonzalez","year":"2002","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00451684","article-title":"Nicotine replacement: Ten-week effects on tobacco withdrawal symptoms","volume":"98","author":"Gross","year":"1989","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10519-006-9115-2","article-title":"Genetics of dopamine and its contribution to cocaine addiction","volume":"37","author":"Haile","year":"2007","journal-title":"Behavior Genetics"},{"issue":"8","key":"10.1016\/bs.irn.2016.02.009_bb0200","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/ajad.12307","article-title":"Altered methamphetamine place conditionng in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine","volume":"24","author":"Haile","year":"2015","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/bs.irn.2016.02.009_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1196\/annals.1316.006","article-title":"Molecular mechanisms underlying the rewarding effects of cocaine","volume":"1025","author":"Hall","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1016\/bs.irn.2016.02.009_bb0210","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/acs.jmedchem.5b00220","article-title":"Combining active immunization with monoclonal antibody therapy to facilitate early initiation of a long-acting anti-methamphetamine antibody response","volume":"58","author":"Hambuchen","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2009.08.031","article-title":"Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans","volume":"67","author":"Haney","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1586\/14760584.3.1.11","article-title":"Therapeutic vaccines for substance dependence","volume":"3","author":"Haney","year":"2004","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/bs.irn.2016.02.009_bb0225","first-page":"CD007072","article-title":"Nicotine vaccines for smoking cessation","volume":"8","author":"Hartmann-Boyce","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"17","key":"10.1016\/bs.irn.2016.02.009_bb0230","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1089\/10430349950016555","article-title":"Cellular immune responses of healthy individuals to intradermal administration of an E1\u2212E3\u2212 adenovirus gene transfer vector","volume":"10","author":"Harvey","year":"1999","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0235","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clpt.2005.08.007","article-title":"Safety and immunogenicity of a nicotine conjugate vaccine in current smokers","volume":"78","author":"Hatsukami","year":"2005","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"8","key":"10.1016\/bs.irn.2016.02.009_bb0245","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/add.12577","article-title":"Treatment with a nicotine vaccine does not lead to changes in brain activity during smoking cue exposure or a working memory task","volume":"109","author":"Havermans","year":"2014","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/bs.irn.2016.02.009_bb0250","first-page":"1070","article-title":"TA-CD. Xenova","volume":"5","author":"Heading","year":"2002","journal-title":"IDrugs"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0255","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mt.2010.280","article-title":"Cocaine analog coupled to disrupted adenovirus: A vaccine strategy to evoke high-titer immunity against addictive drugs","volume":"19","author":"Hicks","year":"2011","journal-title":"Molecular Therapy"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0260","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-3565(24)37155-1","article-title":"Active immunization alters the plasma nicotine concentration in rats","volume":"283","author":"Hieda","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s002130050930","article-title":"Immunization of rats reduces nicotine distribution to brain","volume":"143","author":"Hieda","year":"1999","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/bs.irn.2016.02.009_bb0270","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/add.12573","article-title":"Efficacy of the nicotine vaccine 3\u2032-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: A randomized placebo-controlled trial","volume":"109","author":"Hoogsteder","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/bs.irn.2016.02.009_bb0275","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"1","author":"Hughes","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"17","key":"10.1016\/bs.irn.2016.02.009_bb0280","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained-release bupropion and placebo for smoking cessation","volume":"337","author":"Hurt","year":"1997","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.8.2.163","article-title":"Active cocaine immunization attenuates the discriminative properties of cocaine","volume":"8","author":"Johnson","year":"2000","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/bs.irn.2016.02.009_bb0295","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0300","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF03404152","article-title":"Is there a need for heroin substitution treatment in Vancouver's Downtown Eastside?","volume":"102","author":"Kahan","year":"2011","journal-title":"Canadian Journal of Public Health"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0305","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s002130000555","article-title":"Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010","volume":"153","author":"Kantak","year":"2001","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0315","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14622299050011361","article-title":"Altered disposition of repeated nicotine doses in rats immunized against nicotine","volume":"1","author":"Keyler","year":"1999","journal-title":"Nicotine & Tobacco Research"},{"issue":"11","key":"10.1016\/bs.irn.2016.02.009_bb0320","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.intimp.2008.07.001","article-title":"Enhanced immunogenicity of a bivalent nicotine vaccine","volume":"8","author":"Keyler","year":"2008","journal-title":"International Immunopharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0325","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"10.1016\/bs.irn.2016.02.009_bb0330","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2174\/187152711799219334","article-title":"Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus","volume":"10","author":"Koob","year":"2011","journal-title":"CNS & Neurological Disorders Drug Targets"},{"year":"2005","series-title":"Neurobiology of addiction","author":"Koob","key":"10.1016\/bs.irn.2016.02.009_bb0335"},{"issue":"8","key":"10.1016\/bs.irn.2016.02.009_bb0340","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1517\/14712598.2013.791278","article-title":"Can you vaccinate against substance abuse?","volume":"13","author":"Kosten","year":"2013","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.irn.2016.02.009_bb0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2013.02.037","article-title":"DBH gene as predictor of response in a cocaine vaccine clinical trial","volume":"541","author":"Kosten","year":"2013","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2016.02.009_bb0350","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: A randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0355","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0740-5472(93)90100-G","article-title":"Gender differences in cocaine use and treatment response","volume":"10","author":"Kosten","year":"1993","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0024-3205(86)90437-6","article-title":"A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts","volume":"39","author":"Kosten","year":"1986","journal-title":"Life Sciences"},{"issue":"7\u20138","key":"10.1016\/bs.irn.2016.02.009_bb0365","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","article-title":"Human therapeutic cocaine vaccine: Safety and immunogenicity","volume":"20","author":"Kosten","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/bs.irn.2016.02.009_bb0370","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1521-0391.2014.12152.x","article-title":"Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization","volume":"23","author":"Kosten","year":"2014","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/bs.irn.2016.02.009_bb0375","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","article-title":"A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats","volume":"45","author":"Kosten","year":"2013","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0380","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10550881003684798","article-title":"Pharmacotherapy in the treatment of addiction: Methadone","volume":"29","author":"Kreek","year":"2010","journal-title":"Journal of Addictive Diseases"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2016.02.009_bb0385","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00213-005-0027-2","article-title":"Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats","volume":"184","author":"LeSage","year":"2006","journal-title":"Psychopharmacology"},{"issue":"37","key":"10.1016\/bs.irn.2016.02.009_bb9015","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1039\/C4OB01053A","article-title":"Synthesis and immunological effects of heroin vaccines","volume":"12","author":"Li","year":"2014","journal-title":"Organic and Biomolecular Chemistry"},{"issue":"6","key":"10.1016\/bs.irn.2016.02.009_bb0390","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"A morphine\/heroin vaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb9020","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu093","article-title":"A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats","volume":"18","author":"Li","year":"2015","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0395","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000063629","article-title":"Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats","volume":"69","author":"Lindblom","year":"2002","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0400","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00210-005-0019-0","article-title":"Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs","volume":"372","author":"Lindblom","year":"2005","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0405","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11920-006-0035-x","article-title":"Management of methamphetamine abuse and dependence","volume":"8","author":"Ling","year":"2006","journal-title":"Current Psychiatry Reports"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0410","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000313336","article-title":"Naltrexone implants compared to methadone: Outcomes six months after prison release","volume":"16","author":"Lobmaier","year":"2010","journal-title":"European Addiction Research"},{"issue":"6","key":"10.1016\/bs.irn.2016.02.009_bb0415","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0006-3223(87)90202-2","article-title":"Naltrexone and dysphoria: A double-blind placebo controlled trial","volume":"22","author":"Malcolm","year":"1987","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0420","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1016\/bs.irn.2016.02.009_bb0425","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: A randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0430","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0379-0738(84)90215-9","article-title":"In vivo and in vitro studies on cocaine metabolism: Ecgonine methyl ester as a major metabolite of cocaine","volume":"26","author":"Matsubara","year":"1984","journal-title":"Forensic Science International"},{"issue":"26","key":"10.1016\/bs.irn.2016.02.009_bb0435","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/bs.irn.2016.02.009_bb0440","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.vaccine.2014.01.028","article-title":"Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine","volume":"32","author":"Matyas","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0445","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2013.03.021","article-title":"Enhancing immunogenicity of a 3\u2032aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates","volume":"16","author":"McCluskie","year":"2013","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.irn.2016.02.009_bb0450","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.06.014","article-title":"Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats","volume":"153","author":"Miller","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2016.02.009_bb0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1300\/J069v26S01_07","article-title":"Opiate prescription medication dependence and pain perceptions","volume":"26","author":"Miller","year":"2007","journal-title":"Journal of Addictive Diseases"},{"issue":"8","key":"10.1016\/bs.irn.2016.02.009_bb0460","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","article-title":"A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats","volume":"73","author":"Miller","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0465","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/713688123","article-title":"Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: A placebo controlled study","volume":"2","author":"Molander","year":"2000","journal-title":"Nicotine & Tobacco Research"},{"issue":"17","key":"10.1016\/bs.irn.2016.02.009_bb0470","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1021\/ja108807j","article-title":"Impact of distinct chemical structures for the development of a methamphetamine vaccine","volume":"133","author":"Moreno","year":"2011","journal-title":"Journal of the American Chemical Society"},{"issue":"4064","key":"10.1016\/bs.irn.2016.02.009_bb0475","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.178.4064.984","article-title":"Blood\u2013brain barrier: Penetration of morphine, codeine, heroin, and methadone after carotid injection","volume":"178","author":"Oldendorf","year":"1972","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0480","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11920-007-0049-z","article-title":"The future of vaccines in the management of addictive disorders","volume":"9","author":"Orson","year":"2007","journal-title":"Current Psychiatry Reports"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0485","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1521-0391.2013.00314.x","article-title":"Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: Effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine","volume":"22","author":"Orson","year":"2013","journal-title":"The American Journal on Addictions"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0490","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0091-3057(99)00206-3","article-title":"A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats","volume":"65","author":"Pentel","year":"2000","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"4","key":"10.1016\/bs.irn.2016.02.009_bb0495","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bcp.2011.11.004","article-title":"Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities","volume":"83","author":"Pravetoni","year":"2012","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0500","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"Pravetoni","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"7","key":"10.1016\/bs.irn.2016.02.009_bb0505","doi-asserted-by":"crossref","first-page":"e101807","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/bs.irn.2016.02.009_bb0510","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats","volume":"30","author":"Pravetoni","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/bs.irn.2016.02.009_bb0515","doi-asserted-by":"crossref","first-page":"e115696","DOI":"10.1371\/journal.pone.0115696","article-title":"Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats","volume":"9","author":"Raleigh","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0520","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0525","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0376-8716(98)00135-5","article-title":"Comparing levels of cocaine cue reactivity in male and female outpatients","volume":"53","author":"Robbins","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/bs.irn.2016.02.009_bb0530","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1124\/jpet.107.135111","article-title":"Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats","volume":"325","author":"Roiko","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0535","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"issue":"41","key":"10.1016\/bs.irn.2016.02.009_bb0540","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1016\/j.vaccine.2013.07.038","article-title":"Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food","volume":"31","author":"Ruedi-Bettschen","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0545","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5665\/sleep.4686","article-title":"Varenicline and abnormal sleep related events","volume":"38","author":"Savage","year":"2015","journal-title":"Sleep"},{"issue":"22","key":"10.1016\/bs.irn.2016.02.009_bb0550","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2016.02.009_bb0555","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"Shen","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/bs.irn.2016.02.009_bb0560","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.clinthera.2008.07.019","article-title":"Effect of nicotine lozenges on affective smoking withdrawal symptoms: Secondary analysis of a randomized, double-blind, placebo-controlled clinical trial","volume":"30","author":"Shiffman","year":"2008","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1016\/bs.irn.2016.02.009_bb0565","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4161\/19420862.2014.976431","article-title":"First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers","volume":"6","author":"Stevens","year":"2014","journal-title":"MAbs"},{"issue":"9","key":"10.1016\/bs.irn.2016.02.009_bb0570","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0024-3205(77)90448-9","article-title":"Hydrolysis of cocaine in human plasma by cholinesterase","volume":"20","author":"Stewart","year":"1977","journal-title":"Life Sciences"},{"issue":"14","key":"10.1016\/bs.irn.2016.02.009_bb0575","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"10.1016\/bs.irn.2016.02.009_bb0580","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ntr\/ntt003","article-title":"Niccine(R), a nicotine vaccine, for relapse prevention: A phase II, randomized, placebo-controlled, multicenter clinical trial","volume":"15","author":"Tonstad","year":"2013","journal-title":"Nicotine & Tobacco Research"},{"issue":"5 Suppl.","key":"10.1016\/bs.irn.2016.02.009_bb0585","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1177\/1010539512451853","article-title":"Adult tobacco cessation in Cambodia: I. Determinants of quitting tobacco use","volume":"25","author":"Tonstad","year":"2013","journal-title":"Asia-Pacific Journal of Public Health"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0590","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb9025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/1064-1297.9.2.228","article-title":"Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion","volume":"9","author":"Tuncok","year":"2001","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0595","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(25)32685-6","article-title":"Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice","volume":"218","author":"Umans","year":"1981","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2016.02.009_bb0600","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction","volume":"30","author":"Veilleux","year":"2010","journal-title":"Clinical Psychology Review"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2016.02.009_bb0605","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1360-0443.2007.01772.x","article-title":"Approaches to the development of medications for the treatment of methamphetamine dependence","volume":"102","author":"Vocci","year":"2007","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/bs.irn.2016.02.009_bb0610","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2165\/00023210-200115070-00001","article-title":"Vaccines against nicotine: How effective are they likely to be in preventing smoking?","volume":"15","author":"Vocci","year":"2001","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/bs.irn.2016.02.009_bb0615","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0024-3205(00)00731-1","article-title":"Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain","volume":"67","author":"Volkow","year":"2000","journal-title":"Life Sciences"},{"issue":"37","key":"10.1016\/bs.irn.2016.02.009_bb0620","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1010654108","article-title":"Addiction: Beyond dopamine reward circuitry","volume":"108","author":"Volkow","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.irn.2016.02.009_bb0625","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14622200701704921","article-title":"The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: Results of a randomized, placebo-controlled phase 1\/2 trial","volume":"10","author":"Wagena","year":"2008","journal-title":"Nicotine & Tobacco Research"},{"issue":"5","key":"10.1016\/bs.irn.2016.02.009_bb0630","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/npp.2011.200","article-title":"Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects","volume":"37","author":"Wee","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2016.02.009_bb0635","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02247382","article-title":"Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus","volume":"126","author":"Weissenborn","year":"1996","journal-title":"Psychopharmacology"}],"container-title":["International Review of Neurobiology","Animal Models for Medications Screening to Treat Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774216300095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774216300095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T17:24:45Z","timestamp":1748798685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774216300095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128040133"],"references-count":131,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2016.02.009","relation":{},"ISSN":["0074-7742"],"issn-type":[{"type":"print","value":"0074-7742"}],"subject":[],"published":{"date-parts":[[2016]]}}}